Cargando…
Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis
Autologous haematopoietic stem cell transplantation (AHSCT) is a vital therapeutic option for patients with highly active multiple sclerosis (MS). Rates of remission suggest AHSCT is the most effective form of immunotherapy in controlling the disease. Despite an evolving understanding of the biology...
Autores principales: | Massey, Jennifer, Jackson, Katherine, Singh, Mandeep, Hughes, Brendan, Withers, Barbara, Ford, Carole, Khoo, Melissa, Hendrawan, Kevin, Zaunders, John, Charmeteau-De Muylder, Bénédicte, Cheynier, Rémi, Luciani, Fabio, Ma, David, Moore, John, Sutton, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859174/ https://www.ncbi.nlm.nih.gov/pubmed/35197974 http://dx.doi.org/10.3389/fimmu.2022.798300 |
Ejemplares similares
-
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation
por: Hendrawan, Kevin, et al.
Publicado: (2022) -
Sustained immunotolerance in multiple sclerosis after stem cell transplant
por: Visweswaran, Malini, et al.
Publicado: (2022) -
Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome
por: Cuvelier, Pelagia, et al.
Publicado: (2021) -
Acute Simian Immunodeficiency Virus Infection Triggers Early and Transient Interleukin-7 Production in the Gut, Leading to Enhanced Local Chemokine Expression and Intestinal Immune Cell Homing
por: Ponte, Rosalie, et al.
Publicado: (2017) -
Correlation between thymic output and disease severity in critically ill COVID-19 patients: extended abstract
por: Marouf, Amira, et al.
Publicado: (2022)